Clinical-trial testing exemption and employee bond forfeitures exclude service tax where regulatory approval rests with trial sponsors.
Clinical-trial testing and analysis performed by a clinical research organisation for sponsors holding trial approvals falls within the service-tax exemption where separate approval for the organisation is not issued under the regulatory framework. Strict construction does not justify imposing an impossible approval condition. Employee bond-forfeiture recoveries following premature resignation are compensatory for breach of a service commitment, not consideration for commercial training, coaching, or tolerating an act. Extended limitation requires fraud, suppression, or contravention with intent to evade tax; prior disclosure and a tenable exemption belief do not meet that standard. Consequently, no interest or penalties arise where the underlying tax demands fail.
Issues: (i) Whether technical testing and analysis services rendered by a clinical research organisation undertaking sponsor-approved clinical trials are exempt from service tax under the relevant exemption notifications; (ii) Whether the amount recovered from employees upon premature resignation was taxable as commercial training or coaching service; (iii) Whether invocation of the extended period of limitation was valid; and (iv) Whether interest and penalties were sustainable.
Issue (i): Whether technical testing and analysis services rendered by a clinical research organisation undertaking sponsor-approved clinical trials are exempt from service tax under the relevant exemption notifications.
Analysis: The exemption covered testing and analysis of newly developed drugs on human participants by a clinical research organisation approved to conduct clinical trials by the Drugs Controller General of India. Under the applicable regulatory framework, trial permission is issued to the sponsor, while a clinical research organisation performs delegated trial functions under written arrangements. The clinical research organisation had performed that role for sponsors holding approvals for the concerned trials and had registered the trial activity with the clinical-trials registry. Requiring a separate institutional approval which the regulator did not issue to clinical research organisations would impose an impossible condition. Strict construction of an exemption applies only where genuine ambiguity remains.
Conclusion: The technical testing and analysis services were exempt from service tax; the related demand was unsustainable, in favour of the assessee.
Issue (ii): Whether the amount recovered from employees upon premature resignation was taxable as commercial training or coaching service.
Analysis: The recovery represented a deposit taken from employees trained and appointed subject to a minimum service commitment, refundable upon completion of that commitment and forfeited or recovered upon premature resignation. It was not a fee charged by a commercial training or coaching centre for imparting skill or knowledge. The employer-employee relationship remained one of contract of service. The amount was compensation for breach of the employment commitment and was not consideration for commercial training or coaching or for tolerating an act or situation.
Conclusion: The employee recoveries were not consideration for any taxable service; the demand under commercial training or coaching service was unsustainable, in favour of the assessee.
Issue (iii): Whether invocation of the extended period of limitation was valid.
Analysis: The extended period requires fraud, collusion, wilful misstatement, suppression of facts, or contravention accompanied by intent to evade tax. The Department had sought and received full particulars of the clinical research activity several years before issuance of the notices. Non-registration or non-filing based on a disclosed and tenable belief in exemption did not constitute deliberate suppression or a positive act undertaken with intent to evade tax.
Conclusion: Invocation of the extended period of limitation was invalid, in favour of the assessee.
Issue (iv): Whether interest and penalties were sustainable.
Analysis: As the principal service-tax demands did not survive, interest could not be sustained. Further, the ingredients necessary for penal liability, including suppression or contravention with intent to evade tax, were absent.
Conclusion: Interest and all penalties were unsustainable, in favour of the assessee.
Final Conclusion: The services and employee recoveries were outside the asserted tax liabilities, the extended limitation was unavailable, and no consequential fiscal or penal liability remained.
Ratio Decidendi: An exemption for clinical-research services cannot be construed to require a separate regulatory approval that the competent regulator does not issue to clinical research organisations; and employee bond-forfeiture recoveries are compensatory, not consideration for a taxable service.